Myriad Genetics | MYGN - Current Assets

Stock Price
4.26
Daily Change
-0.03 -0.70%
Monthly
-26.68%
Yearly
-69.09%
Q1 Forecast
4.16

Myriad Genetics reported $344.8M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Exact Sciences USD 1.56B 34.88M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 3.29B 493M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
OraSure Technologies USD 283.01M 18.43M Sep/2025
Pacific Biosciences Of California USD 394.24M 19.16M Sep/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Quidel USD 1.45B 80.6M Dec/2025
Repligen USD 1.1B 39.62M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Standard Biotools USD 472.44M 33.6M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Veracyte USD 449.22M 34.54M Sep/2025
Waters USD 1.99B 69.86M Dec/2025